specific benefit was found for clopidogrel,
mainly due to a decreased risk of non-fatal myocardial infarction.
However, no beneficial effect of clopidogrel was seen on several
other outcomes, including fatal myocardial infarction and cardiovascular
death.Minor, major and specific bleedings such as gastric
bleeding or bleeding requiring transfusion of more than two units
of blood, occurred more often in the clopidogrel group compared
to placebo (a statistically significant difference).